Nikhil Wagle

"Nikhil Wagle"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lloyd MR, Brett JO, Carmeli A, et al. (2024) CDK4/6 Inhibitor Efficacy in -Mutant Metastatic Breast Cancer. Nejm Evidence. 3: EVIDoa2300231
Gómez Tejeda Zañudo J, Barroso-Sousa R, Jain E, et al. (2024) Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature Communications. 15: 2446
Fu X, Pereira R, Liu CC, et al. (2023) High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer. Cell Reports. 42: 112821
Brett JO, Dubash TD, Johnson GN, et al. (2023) A Gene Panel Associated With Abemaciclib Utility in -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. Jco Precision Oncology. 7: e2200532
Crowdis J, Balch S, Sterlin L, et al. (2022) A patient-driven clinicogenomic partnership for metastatic prostate cancer. Cell Genomics. 2
Barroso-Sousa R, Forman J, Collier K, et al. (2022) Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit. Jco Precision Oncology. 6: e2100413
Li Z, McGinn O, Wu Y, et al. (2022) ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. Nature Communications. 13: 2011
Li Z, Wu Y, Yates ME, et al. (2022) Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Research
Qi M, Nayar U, Ludwig LS, et al. (2021) cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries. Bmc Bioinformatics. 22: 611
Alcon C, Gómez Tejeda Zañudo J, Albert R, et al. (2021) ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins. Cells. 10
See more...